dc.contributor.author | Özaslan, E. | |
dc.contributor.author | Koca, S. | |
dc.contributor.author | Sevinç, A. | |
dc.contributor.author | Hacıoğlu, B. | |
dc.contributor.author | Özçelik, M. | |
dc.contributor.author | Duran, A. O. | |
dc.contributor.author | Çiltaş, A. | |
dc.contributor.author | Özgür, Tanrıverdi | |
dc.date.accessioned | 2020-11-20T15:03:12Z | |
dc.date.available | 2020-11-20T15:03:12Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 0028-3835 | |
dc.identifier.issn | 1423-0194 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12809/2682 | |
dc.description | 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease - MAR 09-11, 2016 - Barcelona, SPAIN | en_US |
dc.description | WOS: 000386481600195 | en_US |
dc.description.abstract | [No abstract available] | en_US |
dc.description.sponsorship | ENETS | en_US |
dc.item-language.iso | eng | en_US |
dc.publisher | Karger | en_US |
dc.item-rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Somatostatin Analogue | en_US |
dc.subject | NET | en_US |
dc.subject | Ki-67 | en_US |
dc.title | Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 <= 20% | en_US |
dc.item-type | conferenceObject | en_US |
dc.contributor.department | MÜ,Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.contributor.institutionauthor | Özgür, Tanrıverdi | |
dc.identifier.volume | 103 | en_US |
dc.identifier.startpage | 74 | en_US |
dc.identifier.endpage | 74 | en_US |
dc.relation.journal | Neuroendocrinology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |